Canada· CA-DIN-02268825
ANGELIQ
A drospirenon und estrogen product containing drospirenone + estradiol, registered in Canada by BAYER INC. The same ATC class is registered in 8 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Drospirenon und estrogen is registered in 8 of 19 countries.
Countries holding a registration under ATC G03FA17 (drospirenon und estrogen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Drospirenon und estrogen · ATC G03FA17
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- DROSPIRENONE + ESTRADIOL
- Manufacturer
- BAYER INC
- Country
- Canada (CA)
- ATC code
- G03FA17
- ATC class
- Drospirenon und Estrogen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
12 interactions on record for drospirenon und estrogen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenon und estrogen · interactions on record
12 records
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Drospirenon und estrogen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAllureneBayer Schering Pharma Oy
- GermanyAngeliqBayer Vital Gmbh
- SpainANGELIQ 1 mg/2 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Hispania S.L.
- United KingdomAngeliq 1mg/2mg tabletsBayer Plc
- SwitzerlandAngeliq
- NetherlandsAngeliq, 1 mg/2 mg filmomhulde tablettenBayer B.V.
- United StatesAngeliqBayer HealthCare Pharmaceuticals Inc.
- ItalyANGELIQBAYER S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Angeliq, Klimedix
- Czechia · Angeliq, Paosonelle
- Germany · Angeliq, Klimedix
- Estonia · Angeliq
- Spain · Angeliq
- Finland · Angeliq
- Croatia · Angeliq
- Ireland · Angeliq
- Italy · Angeliq, Paosonelle
- Lithuania · Angeliq
- Luxembourg · Angeliq
- Latvia · Angeliq, Klimedix
- Malta · Angeliq
- Netherlands · Angeliq, Paosonelle
- Poland · Angeliq
- Portugal · Angeliq, Klimedix
- Slovenia · Angeliq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cea1241a-515f-4cc7-a4e5-8330bd0480c9 GET /v1/drugs/cea1241a-515f-4cc7-a4e5-8330bd0480c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02268825",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "G03FA17",
"schedule": [
"Prescription"
],
"drug_code": "75422",
"strengths": [
"1.0 MG"
],
"ahfs_class": null,
"substances": [
"DROSPIRENONE",
"ESTRADIOL"
],
"product_categorization": null
}See everything about drospirenon und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.